RxDoctor Payments Data

Samantha Grundemann, PA

Physician Assistant · Marshall, MINPI 1821490459

Payments from drug & device makers

$1,496in general payments, 2019–2025

Across 81 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$401
  • AbbVie$312
  • Merck$97
  • AstraZeneca$95
  • Lundbeck LLC$86
  • Pfizer$83
  • plus $422 from 13 others

What the payments were for

  • Food & beverage$1,496100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,496 in reported general payments places this provider in the 80th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$29,851
Medicare patients
139
Services billed
365

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide40$60,966
EliquisApixaban45$34,837
FarxigaDapagliflozin Propanediol21$34,313
MounjaroTirzepatide25$28,605
JanuviaSitagliptin Phosphate18$25,784
XareltoRivaroxaban16$23,853
MyrbetriqMirabegron18$19,783
TrulicityDulaglutide16$15,707
LevemirInsulin Detemir11$4,400
Atorvastatin Calcium315$4,308
Aripiprazole19$2,588
Metoprolol Succinate128$2,562
Levothyroxine Sodium192$2,168
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$2,158
Omeprazole112$1,950

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Levemir$401$65,36751 claims
Lilly USA, LLCMounjaro, Trulicity$40$44,31241 claims
PfizerEliquis$83$34,83745 claims
AstraZenecaFarxiga$95$34,31321 claims
MerckJanuvia$97$25,78418 claims
Astellas Pharma US IncMyrbetriq$37$19,78318 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Marshall

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →